Patient-driven Management of BP in CKD
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT05546099
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Self-management of BP medications — BEHAVIORALPatients will be educated on how to manage their home BP based on a pre-determined protocol. They will then monitor home BP and adjust meds accordingly and under the guidance of the clinical pharmacist.
- Self-monitoring of home BP — BEHAVIORALPatients will be educated on how to monitor home BP and will be educated to contact their primary care provider/CKD provider if the BP is above the goal.
Study Details
The proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney disease (CKD) will be included in the study. The study will further evaluate factors that may influence the Veteran to accept the self-management approach and what factors in the VHA healthcare system affect the implementation of the self-management approach.
Key Dates
- Start date
- Dec 15, 2022
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2026
- Completion
- Nov 20, 2026
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Self-managementPatients monitor their home BP and self manage their BP medications based on a predesigned titration protocol and under the guidance of the clinical pharmacist.
- Active Comparator: Self-monitoringPatients monitor their home BP and contact their provider if the BP is above the goal.
Primary Outcome Measure
Change in standardized office BP [ Time Frame: 12 months ]
Central Contacts
- Diana Jalal, MD(319) 338-0581
- Katharine M Geasland, RN(319) 353-6318
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Iowa City VA Health Care System, Iowa City, IA | Iowa City | Iowa | 52246-2292 | Diana Jalal, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Iowa City, IA
By condition
By specialty
By research site
Related Studies
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaPHASE3 · Recruiting · Bayer · Phoenix, Arizona
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaPHASE3 · Recruiting · Bayer · Phoenix, Arizona
- Empagliflozin Treatment in Kidney Transplant RecipientsPHASE4 · Recruiting · VA Office of Research and Development · Hines, Illinois
- Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)Recruiting · Johns Hopkins Bloomberg School of Public Health · Kansas City, Missouri